(Q37789033)

23 August 2017

Tumor markers for early detection of ovarian cancer (English)

1 reference

23 August 2017

1 reference

Juan Ren

1

1 reference

23 August 2017

Hui Cai

2

1 reference

23 August 2017

Yi Li

3

1 reference

23 August 2017

Xiaozhi Zhang

4

1 reference

23 August 2017

Zi Liu

5

1 reference

23 August 2017

Jian-Sheng Wang

6

1 reference

23 August 2017

Yi Lisa Hwa

7

1 reference

23 August 2017

Yuelang Zhang

8

1 reference

23 August 2017

Ya Yang

9

1 reference

23 August 2017

Yu Li

10

1 reference

23 August 2017

Shi-Wen Jiang

11

1 reference

23 August 2017

1 September 2010

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

23 August 2017

1 reference

23 August 2017

10

1 reference

23 August 2017

6

1 reference

23 August 2017

787-798

1 reference

Recent technical strategies to identify diagnostic biomarkers for ovarian cancer

23 August 2017

1 reference

Advances, challenges, and limitations in serum-proteome-based cancer diagnosis

21 January 2018

1 reference

Screening for ovarian cancer: a pilot randomised controlled trial.

21 January 2018

1 reference

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

21 January 2018

1 reference

Status of Tumor Markers in Ovarian Cancer Screening

21 January 2018

1 reference

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

21 January 2018

1 reference

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

21 January 2018

1 reference

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

21 January 2018

1 reference

Serum tumor markers in the management of ovarian, endometrial and cervical cancer

21 January 2018

1 reference

Colorectal carcinoma antigens detected by hybridoma antibodies

21 January 2018

1 reference

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

21 January 2018

1 reference

Early detection of ovarian cancer using group biomarkers.

21 January 2018

1 reference

Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer

21 January 2018

1 reference

Potential markers that complement expression of CA125 in epithelial ovarian cancer

21 January 2018

1 reference

A Major Human Epididymis-Specific cDNA Encodes a Protein with Sequence Homology to Extracellular Proteinase Inhibitors1

21 January 2018

1 reference

Current state of biomarker development for clinical application in epithelial ovarian cancer

21 January 2018

1 reference

Biomarkers of ovarian tumours

21 January 2018

1 reference

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

21 January 2018

1 reference

Bead-based ELISA for validation of ovarian cancer early detection markers

21 January 2018

1 reference

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

21 January 2018

1 reference

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

21 January 2018

1 reference

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology

21 January 2018

1 reference

Prostasin, a potential tumor marker in ovarian cancer--a pilot study

21 January 2018

1 reference

Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers.

21 January 2018

1 reference

The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase-Prostasin serine protease cascade in cultured epithelial cells

21 January 2018

1 reference

Osteopontin as a potential diagnostic biomarker for ovarian cancer

21 January 2018

1 reference

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

21 January 2018

1 reference

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

21 January 2018

1 reference

Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.

21 January 2018

1 reference

Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment

21 January 2018

1 reference

Overexpression of kallikrein 10 in epithelial ovarian carcinomas

21 January 2018

1 reference

Predicting biomarkers for ovarian cancer using gene-expression microarrays

21 January 2018

1 reference

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer

21 January 2018

1 reference

Validation of serum biomarkers for detection of early-stage ovarian cancer.

21 January 2018

1 reference

Serum protein markers for early detection of ovarian cancer

21 January 2018

1 reference

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer

21 January 2018

1 reference

Characterization of serum biomarkers for detection of early stage ovarian cancer

21 January 2018

1 reference

Plasma proteomic pattern as biomarkers for ovarian cancer

21 January 2018

1 reference

Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine

21 January 2018

1 reference

Biomarker discovery for ovarian cancer using SELDI-TOF-MS.

21 January 2018

1 reference

Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains

21 January 2018

1 reference

Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.

21 January 2018

1 reference

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

21 January 2018

1 reference

Comparative proteome analysis of human epithelial ovarian cancer.

21 January 2018

1 reference

Ovarian cancer proteomics: Many technologies one goal

21 January 2018

1 reference

Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.

21 January 2018

1 reference

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study

21 January 2018

1 reference

Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers

21 January 2018

1 reference

Development and validation of a protein-based signature for the detection of ovarian cancer

21 January 2018

1 reference

Diagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral Data

21 January 2018

1 reference

Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications

21 January 2018

1 reference

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples

21 January 2018

1 reference

B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer

21 January 2018

1 reference

A Proteome Resource of Ovarian Cancer Ascites: Integrated Proteomic and Bioinformatic Analyses To Identify Putative Biomarkers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.10.39

1 reference

23 August 2017

1 reference